Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maruchi is a South Korea-based dental materials company focused on endodontics and regenerative dental products. The company develops and commercializes bioceramic and mineral trioxide aggregate (MTA)-based products for root canal repair, sealing, disinfection, and vital pulp therapy, along with oral care and dental regenerative offerings. Its marketed portfolio includes Endocem, Endoseal, White Endoseal Bioceramic Sealer, CleaniCal, Endosonic Blue 2, Tomy Tip, and EndoRoad file systems. Maruchi states that it operates manufacturing in a clean-room batch production line in Wonju Medical Industry Techno Valley and conducts R&D through an affiliated research institute. The business appears to be product-commercial rather than a therapeutic drug developer, serving dental professionals in Korea and international markets including the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maruchi.